Case report: reporting anti-G as anti-C+D may have misleading clinical implications

A L Mosley1, M B Trich, N C Thomas

  • 1Department of Pathology, Georgetown University Medical Center, Washington, DC, USA.

Immunohematology
|January 1, 1997
PubMed

Insights

A D- male developed anti-G antibodies after transfusion, not anti-C+D as initially suspected. This highlights the importance of accurate blood group serology to avoid misinterpreting alloimmunization.

Area of Science:

  • Transfusion Medicine
  • Blood Group Serology
  • Immunology

Background:

  • Alloimmunization to red blood cell (RBC) antigens can complicate transfusions.
  • Accurate identification of antibodies is crucial for patient safety.
  • The D antigen and related antigens (C, G) are significant in transfusion medicine.

Purpose of the Study:

  • To investigate a case of suspected anti-D alloimmunization in a D- individual.
  • To differentiate between anti-C+D and anti-G antibodies.
  • To emphasize the importance of accurate blood group serology interpretation.

Main Methods:

  • Standard pretransfusion antibody screening and alloantibody identification panel.
  • Review of hospital transfusion records.
  • Consultation with a reference laboratory.
  • Additional serologic testing for antibody identification.

Main Results:

  • An antibody initially reported as anti-C+D was detected in a D- male after transfusion with D- RBCs.
  • Further testing confirmed the antibody was anti-G, not anti-C+D.
  • The stimulus for anti-G was identified as a C+D- RBC unit from a G+ donor.

Conclusions:

  • Serologic reactions for anti-C+D can be mistaken for anti-G.
  • Misinterpretation can lead to erroneous conclusions about alloimmunization and transfusion history.
  • Confirmatory testing and awareness of anti-G are essential for healthcare providers.